Bayer logo

Bayer

Last updated January 31, 2026
432
Innovation Areas
13,147
Inventors
104
Collaborations

Encapsulated ketoenol and pyrethroid suspensions: BayerRecent Research Landscape

Active ingredient instability in pyrethroid mixtures leads to premature degradation and reduced shelf-life. Precise solvent selection stabilizes the suspension concentrate to maintain bio-efficacy during storage.

What technical problems is Bayer addressing in Encapsulated ketoenol and pyrethroid suspensions?

Active ingredient chemical instability

(27)evidences

Uncontrolled movement of pesticide droplets during application leads to environmental contamination and reduced efficacy. Minimizing this loss ensures precise delivery of active ingredients to the intended site.

Uncontrolled therapeutic release rates

(19)evidences

Poor solubility and physical instability of complex molecules like emodepside limit therapeutic efficacy. Preventing crystallization and maintaining stability ensures consistent drug delivery and absorption.

Pesticide environmental degradation and volatility

(12)evidences

Premature degradation of sensitive insecticidal compounds in liquid environments. Preventing chemical breakdown ensures long-term efficacy and shelf-life.